CHANGES IN BIOMARKER STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

被引:0
|
作者
Matsumoto, A. [1 ]
Takahashi, M. [1 ]
Hayashida, T. [1 ]
Hirose, S. [2 ]
Jinno, H. [1 ]
Kitagawa, Y. [1 ]
机构
[1] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan
[2] Keio Univ, Sch Med, Tokyo, Japan
来源
BREAST | 2013年 / 22卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S64 / S64
页数:1
相关论文
共 50 条
  • [1] Biomarker Changes After Neoadjuvant Chemotherapy for Breast Cancer
    Maguire, Aoife
    Hudson, Andrew
    Jagas, Jacob
    Quinn, Cecily
    LABORATORY INVESTIGATION, 2023, 103 (03) : S178 - S178
  • [2] Breast Cancer Biomarkers before and after Neoadjuvant Chemotherapy: Do Changes in Biomarker Status Impact Therapeutic Management?
    Quinones, Alexander K.
    Tozbikian, Gary
    Zynger, Debra L.
    MODERN PATHOLOGY, 2016, 29 : 67A - 68A
  • [3] Breast Cancer Biomarkers before and after Neoadjuvant Chemotherapy: Do Changes in Biomarker Status Impact Therapeutic Management?
    Quinones, Alexander K.
    Tozbikian, Gary
    Zynger, Debra L.
    LABORATORY INVESTIGATION, 2016, 96 : 67A - 68A
  • [4] Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy
    Zarotti, Cristina
    Papassotiropoulos, Barbel
    Elfgen, Constanze
    Dedes, Konstantin
    Vorburger, Denise
    Pestalozzi, Bernhard
    Trojan, Andreas
    Varga, Zsuzsanna
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy
    Cristina Zarotti
    Bärbel Papassotiropoulos
    Constanze Elfgen
    Konstantin Dedes
    Denise Vorburger
    Bernhard Pestalozzi
    Andreas Trojan
    Zsuzsanna Varga
    Scientific Reports, 12
  • [6] Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer
    Matsumoto, A.
    Jinno, H.
    Ando, T.
    Fujii, T.
    Nakamura, T.
    Saito, J.
    Takahashi, M.
    Hayashida, T.
    Kitagawa, Y.
    BREAST, 2015, 24 : S96 - S97
  • [7] Assessment of biomarker changes in breast cancer in initial, intermediate CNB and in resection specimen after neoadjuvant chemotherapy
    Kudaybergenova, A.
    Khadzhimatova, S.
    Gigolaeva, L.
    Krivorotko, P.
    Artemyeva, A.
    VIRCHOWS ARCHIV, 2017, 471 : S297 - S297
  • [8] Changes in Hormone Receptor and Her2 Status After Neoadjuvant Chemotherapy in Breast Cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Yamac, Deniz
    Coskun, Ugur
    Yildiz, Ramazan
    Yaman, Emel
    Ozturk, Banu
    Benekli, Mustafa
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30 (02): : 469 - 473
  • [9] Changes in ER, PR and HER2 receptors status after neoadjuvant chemotherapy in breast cancer
    Yang, Yu-Feng
    Liao, Ying-Yang
    Li, Le-Qun
    Xie, Shu-Rui
    Xie, Yan-Fang
    Peng, Ning-Fu
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (12) : 797 - 802
  • [10] Impact of Neoadjuvant Chemotherapy on Biomarker Expression in Breast Cancer
    Lee, Su Ji
    Kim, Ahrong
    Kim, Jee Yeon
    Choi, Kyung Un
    Kwon, Soon Wook
    Lee, Yury
    Ahn, Jihyun
    Jung, Se Jin
    Kim, Kyungbin
    Huh, Gi Yeong
    Lee, Chang Hun
    Shin, Dong Hoon
    LABORATORY INVESTIGATION, 2023, 103 (03) : S163 - S165